Consulta Global sobre a Investigação Relacionada à Infecção pelo Vírus Zika, em Genebra

Details

A Organização Mundial de Saúde (OMS) realizou em Genebra, entre os dias 7 e 9 de março, a Consulta Global sobre a Investigação Relacionada à Infecção pelo Vírus Zika. O evento, que reuniu pesquisadores de todo o mundo, abordou a epidemia do vírus zika e a microcefalia, trazendo informações sobre situação epidemiológica, diagnóstico, tratamento, vacina, entre outros temas. Os trabalhos apresentados podem ser conferidos abaixo.

Background and Epidemiology:

Current epidemiological features, timeline of events and major concerns Zika virus syndrome

Flaviviruses, An Overview

Public Health Research:

Associations between Zika virus infection, microcephaly and Guillain-Barré Syndrome

Zika pathogenesis and the design of novel interventions

Clinical Characterization, Natural History, and Complications of Zika in the context of co-circulating Arboviruses in Latin America

Epidemiological modelling: Implications for Zika control measures

Towards the Development of a research agenda for characterizing the Zika virus outbreak

Key PH Research studies discussed at PAHO

Pathogenesis of microcephaly

Elements to consider in research protocols for diagnostic tools and methods

Which elements should be considered in the research protocols with regards to Pathogenesis

Which elements should be considered in the research protocols with regards to Vectors

Vaccines:

NIAID efforts in Zika animal model development

Zika virus mouse model

Overview of the draft vaccine TPP

Overview of the R&D Blueprint

Landscape analysis on Zikavirus vaccine development - preliminary findings

Zika viruses for vaccine development

Diagnostics

Overview of the draft diagnostic TPP

Zika Diagnostics - Product Development Landscape and Needs

The EUAL process for diagnostics

Vector Control

Modelling the introduction of vectors designed to reduce disease burden

Modelling the introduction of vectors designed to reduce disease burden

Review of the vector control landscape

Regulatory

Candidate reference preparations for candidate Zika products - serology
 

Development of a Candidate WHO International Standard for Zika Virus for NAT Assays

Collaborative regulatory support for emerging infectious diseases

Offers of support from regulatory agencies to evaluate candidate Zika products

Key regulatory issues for candidate Zika products

Therapeutics

Immunopathology of Guillain-Barré syndrome

Understanding Zika virus infections and pathogenesis for treatment product development

Zika virus Lessons learnt from the French Polynesian outbreak

Zika virus Associated with Microcephaly

Data and sample sharing

Biobanking and sample-sharing for priority diseases

European Virus Archive goes Global

Zika R&D: Data sharing panel

Data Sharing: from expectation to implementation

Open science approach to data sharing

Zika Open